melanoma vaccine

melanoma vaccine

Any of a number of experimental cancer vaccines prepared from human melanoma cells, none of which have been particularly successful in slowing or stopping the progression of higher stage/metastatic melanoma.
References in periodicals archive ?
To make a melanoma vaccine, the researchers developed an antigen that includes a marker frequently overexpressed by melanoma cells, as well as an adjuvant, which creates a generalised danger signal for the immune system and boosts its response.
"The published data on the melanoma vaccine is a bit of a mixed bag," says Dr.
Discussion regarding melanoma vaccine clinical trials and a hematology and oncology referral took place.
Our lead product is MBFT-201, a canine melanoma vaccine for dogs with Stage II/III resectable disease.
Eisenberg et al., "Immune monitoring of patients treated with a whole-cell melanoma vaccine engineered to express 4-1BBL," Journal of Immunotherapy, vol.
has discussed the adjuvant autologous melanoma vaccine for macroscopic stage III disease.
(31) Because of the force with which the vaccine is propelled through the skin, alternative methods of delivery may need to be explored if the melanoma vaccine is attempted in avian patients.
Contract award: service in the conduct and monitoring of the clinical research acronym etam 2 - 5 (therapeutic melanoma vaccine) implemented within the framework of the project "personalization of melanoma therapeutic vaccination" ("personalization therapeutic vaccination in patients with melanoma") program innomed.
A second treatment now in large clinical trials could revive fading hopes for a melanoma vaccine. At the same time, many scientists now acknowledge that vaccines probably can't do the job alone.
M2 EQUITYBITES-11 May 2010-Scancell Holdings plc signs licensing agreement for SCIB1 melanoma vaccine components(C)2010 M2 COMMUNICATIONS http://www.m2.com
5 May 2010 - UK-based developer of therapeutic cancer vaccines Scancell Holdings Plc (LON: SCLP) announced today that its proposal to conduct a Phase I clinical trial on melanoma vaccine SCIB1 has been approved in UK by the Gene Therapy Advisory Committee (GTAC) and by the Medicines and Healthcare products Regulatory Agency (MHRA) Medicines Division.
Full browser ?